Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 365 results for "lymphocyte count"

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market -...

Forecast & Market Forecast in G8 Countries) (2011 - 2020) 04/03 11:43 CDT Forecast & Market Forecast in G8 Countries) (2011 - 2020) LONDON, April 3, 2014 LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market ... Finwin, 2 weeks ago

1 images for "lymphocyte count"

Glia, 4 months ago

Is Absolute Lymphocyte Count a Good Prognostic Predictor in Recurrence of Hepatocellular Carcinoma After Liver Transplantation?

Remember me What does "Remember me" mean? By checking this box, you'll stay logged in for 14 days or until you logout. You'll get easier access to your articles, collections, media, and all your ...
 Transplantation1 month ago Peritransplant Lymphopenia Is a Novel Prognostic Factor in Recurrence of Hepatocellular Carcinoma After Liver Transplantation  Transplantation1 month ago

Vemurafenib decreased lymphocyte counts, altered T-cells in melanoma

Vemurafenib and dabrafenib demonstrated similar efficacy in patients with melanoma, but only vemurafenib treatment was associated with decreased peripheral lymphocyte counts and altered CD4-positive T-cell phenotype and function, according to study ...
 Orthopedics Today1 month ago
4 Traders

Pharmacyclics Announces Presentation of Phase III and Long Term Follow Up Data on IMBRUVICA in Chronic Lymphocytic Leukemia (CLL) at ASCO

SUNNYVALE, Calif. "At the interim analysis of the RESONATE Phase III study in January, the data showed that IMBRUVICA improved with statistical significance the overall survival of patients with relapsed or refractory CLL versus ofatumumab, an ...
 PR Newswire2 days ago Pharmacyclics : Announces Presentation of Phase III and Long Term Follow Up Data on IMBRUVICA in Chronic Lymphocytic Leukemia (CLL) at ASCO  4 Traders2 days ago Janssen Research & Development Release: Supplemental New Drug Application For IMBRUVICA (ibrutinib) Submitted To The U.S. FDA  BioSpace2 weeks ago Pharmacyclics Files Supplemental New Drug Application for IMBRUVICA with Phase III CLL Study Data  Benzinga.com2 weeks ago
[x]  

Lymphocytic Pleural Effusion and Change of the Adenosine Deaminase Cut-Off Level in Tuberculosis Diagnosis

SESSION TITLE: Pleural Disease/Pleural Effusion Posters SESSION TYPE: Poster Presentations PRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PM PURPOSE: To assess the discriminatory power of pleural ADA levels in pleural effusions ...
 CHEST1 month ago

Cancers in HIV/AIDS: Epidemiology, Therapeutic Challenges

Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 2002; 94:12041210. Schneider E, Whitmore S, Glynn KM, ...
 Medscape1 month ago

Erratum: Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

Correction N Engl J Med 2014; 370:786 February 20, 2014 DOI: 10.1056/NEJMx140003 Article Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia ( Original Article, N Engl J Med 2013 ; 369 : 32 - 42 ) . In the ...
 New England Journal of Medicine2 months ago
MedIndia

The number of tumor cells spread to sentinel lymph nodes affects melanoma prognosis

PUBLIC RELEASE DATE: 18-Feb-2014 Cancer cell spread to the sentinel node—the lymph node to which cancer cells are most likely to spread from a primary tumor—is a risk factor for melanoma death. According to a study published in this week's ...
 EurekAlert!2 months ago Melanoma prognosis affected by number of tumor cells spread to sentinel lymph nodes  Medical News Today2 months ago Melanoma Prognosis Determined by Tumor Cells Spreading to Sentinel Lymph Nodes  MedIndia2 months ago

CXCR4 Is Dispensable for T Cell Egress from Chronically Inflamed Skin via the Afferent Lymph

T cell recirculation through extralymphoid tissues is essential to immune surveillance, host defense and inflammation. In this process, T cells enter the tissue from the blood and subsequently leave via the afferent lymph. In the absence of ...
 PLoS Medicine1 day ago

GSK and Genmab receive FDA approval for Arzerra(r) (ofatumumab) as first-line

treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate treatment in combination with chlorambucil for patients with Chronic Lymphocytic ...
 Finwin6 days ago GLAXOSMITHKLINE : GSK and Genmab receive FDA approval for Arzerra (ofatumumab) as first-line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate  4 Traders5 days ago 4/17/14 - GSK and Genmab Receive FDA Approval for Arzerra® (ofatumumab) as First-Line Treatment in Combination with Chlorambucil for Patients with Chronic Lymphocytic Leukemia (CLL) for Whom Fludarabine-Based Therapy is Considered Inappropriate  Pharmacy Choice5 days ago GENMAB A/S : GSK and Genmab Receive FDA Approval for Arzerra(r) (ofatumumab) as First-Line Treatment in Combination with Chlorambucil for Patients with Chronic Lymphocytic Leukemia (CLL) for Whom Fludarabine-Based Therapy is Considered Inappropriate  4 Traders6 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less